GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Veracyte Inc (FRA:12V) » Definitions » Cash Flow for Lease Financing

Veracyte (FRA:12V) Cash Flow for Lease Financing : €0.0 Mil (TTM As of Dec. 2023)


View and export this data going back to 2013. Start your Free Trial

What is Veracyte Cash Flow for Lease Financing?

Veracyte's Cash Flow for Lease Financing for the three months ended in Dec. 2023 was €0.0 Mil. Veracyte's Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Dec. 2023 was €0.0 Mil.

Compared with last quarter (€0.0 Mil in Sep. 2023 ), Veracyte's Cash Flow for Lease Financing remained the same in Dec. 2023 (€0.0 Mil).

Veracyte Cash Flow for Lease Financing Historical Data

The historical data trend for Veracyte's Cash Flow for Lease Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Veracyte Cash Flow for Lease Financing Chart

Veracyte Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash Flow for Lease Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Veracyte Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cash Flow for Lease Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Veracyte Cash Flow for Lease Financing Calculation

Cash Flow for Lease Financing is change in cash flow resulting from increase or decrease in lease financing.


Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Veracyte Cash Flow for Lease Financing Related Terms

Thank you for viewing the detailed overview of Veracyte's Cash Flow for Lease Financing provided by GuruFocus.com. Please click on the following links to see related term pages.

Veracyte (FRA:12V) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Veracyte Inc (FRA:12V) » Definitions » Cash Flow for Lease Financing
Comparable Companies
BEAM PTCT SWTX SMMT PNT RYTM IDYA VCEL CPRX ACLX OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
VCYT:USA
Address
6000 Shoreline Court, Suite 300, South San Francisco, CA, USA, 94080
Website
https://www.veracyte.com
Veracyte Inc is a genomic diagnostics company. It provides genomic diagnostic products and services to improve patient care against diseases such as thyroid cancer, lung cancer, and idiopathic pulmonary fibrosis. The firm's product portfolio consists of products such as Afirma analysis, Percepta, Envisia, and others. The company derives its revenues from the Sale of Afirma analysis products.

Veracyte (FRA:12V) Headlines

No Headlines